Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2011, Article ID 753917, 11 pages
http://dx.doi.org/10.1155/2011/753917
Research Article

Atherogenic ω-6 Lipids Modulate PPAR- EGR-1 Crosstalk in Vascular Cells

1Department of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA
2Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, LA, USA

Received 30 April 2011; Revised 17 June 2011; Accepted 11 July 2011

Academic Editor: R. P. Phipps

Copyright © 2011 Jia Fei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Khachigian, “Early growth response-1 in cardiovascular pathobiology,” Circulation Research, vol. 98, no. 2, pp. 186–191, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. U. R. Pendurthi, J. T. Williams, and L. V. M. Rao, “Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin: suppression of activation of transcription factors Egr-1, AP-1, and NF-κB,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 12, pp. 3406–3413, 1997. View at Google Scholar · View at Scopus
  3. J. Yao, N. Mackman, T. S. Edgington, and S. T. Fan, “Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors,” Journal of Biological Chemistry, vol. 272, no. 28, pp. 17795–17801, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Bao, C. Lu, and J. A. Frangos, “Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: role of NO, NFκB, and egr-1,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 996–1003, 1999. View at Google Scholar · View at Scopus
  5. R. K. Giri, S. K. Selvaraj, and V. K. Kalra, “Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA,” Journal of Immunology, vol. 170, no. 10, pp. 5281–5294, 2003. View at Google Scholar · View at Scopus
  6. T. Maekawa, N. Takahashi, T. Honda et al., “Porphyromonas gingivalis antigens and interleukin-6 stimulate the production of monocyte chemoattractant protein-1 via the upregulation of early growth response-1 transcription in human coronary artery endothelial cells,” Journal of Vascular Research, vol. 47, no. 4, pp. 346–354, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Goetze, U. Kintscher, K. Kaneshiro et al., “TNFα induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2,” Atherosclerosis, vol. 159, no. 1, pp. 93–101, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Z. Duan, M. G. Usher, and R. M. Mortensen, “PPARs: the vasculature, inflammation and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 2, pp. 128–133, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. Robinson and D. J. Grieve, “Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease,” Pharmacology and Therapeutics, vol. 122, no. 3, pp. 246–263, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. N. Marx, H. Duez, J. C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells,” Circulation Research, vol. 94, no. 9, pp. 1168–1178, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. E. Law, S. Goetze, X. P. Xi et al., “Expression and function of PPARγ in rat and human vascular smooth muscle cells,” Circulation, vol. 101, no. 11, pp. 1311–1318, 2000. View at Google Scholar · View at Scopus
  12. S. T. de Dios, R. C. O'Brien, and P. J. Little, “Clinical thiazolidinediones as PPARγ ligands with the potential for the prevention of cardiovascular disease in diabetes,” Current Diabetes Reviews, vol. 2, no. 2, pp. 227–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Israelian-Konaraki and P. D. Reaven, “Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications,” Cardiology in Review, vol. 13, no. 5, pp. 240–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Fruchart, “Peroxisome proliferator-activated receptor-alpha (PPARα): at the crossroads of obesity, diabetes and cardiovascular disease,” Atherosclerosis, vol. 205, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. Altman, D. D. Motton, R. S. Kota, and J. C. Rutledge, “Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARα and NF-κB,” Vascular Pharmacology, vol. 48, no. 2-3, pp. 76–84, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. V. R. Babaev, H. Ishiguro, L. Ding et al., “Macrophage expression of peroxisome proliferator-activated receptor-α reduces atherosclerosis in low-density lipoprotein receptor-deficient mice,” Circulation, vol. 116, no. 12, pp. 1404–1412, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. Krönke, A. Kadl, E. Ikonomu et al., “Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 6, pp. 1276–1282, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. J. Barlic and P. M. Murphy, “An oxidized lipid-peroxisome proliferator-activated receptor γ-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion,” Trends in Cardiovascular Medicine, vol. 17, no. 8, pp. 269–274, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. Y. Jung, S. Song, and C. Choi, “Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species,” Immunology Letters, vol. 117, no. 1, pp. 63–69, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Okada, S. F. Yan, and D. J. Pinsky, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets,” FASEB Journal, vol. 16, no. 14, pp. 1861–1868, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Ichihara, K. Obata, Y. Yamada et al., “Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors,” Journal of Molecular and Cellular Cardiology, vol. 41, no. 2, pp. 318–329, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Fu, J. Zhang, Y. Lin, X. Zhu, M. U. Ehrengruber, and Y. E. Chen, “Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ1 gene expression in human aortic smooth muscle cells,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 26808–26814, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Fu, J. Zhang, Y. Lin et al., “Early stimulation and late inhibition of peroxisome proliferator-activated receptor γ (PPARγ) gene expression by transformino growth factor β in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads,” Biochemical Journal, vol. 370, no. 3, pp. 1019–1025, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. Delerive, C. Furman, E. Teissier, J. C. Fruchart, P. Duriez, and B. Staels, “Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner,” FEBS Letters, vol. 471, no. 1, pp. 34–38, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Nagy, P. Tontonoz, J. G. A. Alvarez, H. Chen, and R. M. Evans, “Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ,” Cell, vol. 93, no. 2, pp. 229–240, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. S. A. Kliewer, J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann, “A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation,” Cell, vol. 83, no. 5, pp. 813–819, 1995. View at Google Scholar · View at Scopus
  27. B. M. Forman, P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans, “15-deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ,” Cell, vol. 83, no. 5, pp. 803–812, 1995. View at Google Scholar · View at Scopus
  28. J. T. Huang, J. S. Welch, M. Ricote et al., “Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase,” Nature, vol. 400, no. 6742, pp. 378–382, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. T. Itoh, L. Fairall, K. Amin et al., “Structural basis for the activation of PPARγ by oxidized fatty acids,” Nature Structural and Molecular Biology, vol. 15, no. 9, pp. 924–931, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. K. W. Nettles, “Insights into PPARγ from structures with endogenous and covalently bound ligands,” Nature Structural and Molecular Biology, vol. 15, no. 9, pp. 893–895, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Whelan, “The health implications of changing linoleic acid intakes,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 79, no. 3-5, pp. 165–167, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. P. M. Kris-Etherton, K. D. Hecker, and A. E. Binkoski, “Polyunsaturated fatty acids and cardiovascular health,” Nutrition Reviews, vol. 62, no. 11, pp. 414–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. M. Berry, “Who's afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 11, no. 3, pp. 181–188, 2001. View at Google Scholar · View at Scopus
  34. I. Staprans, J. H. Rapp, X. M. Pan, D. A. Hardman, and K. R. Feingold, “Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 4, pp. 533–538, 1996. View at Google Scholar · View at Scopus
  35. N. Totani, M. Burenjargal, M. Yawata, and Y. Ojiri, “Chemical properties and cytotoxicity of thermally oxidized oil,” Journal of Oleo Science, vol. 57, no. 3, pp. 153–160, 2008. View at Google Scholar · View at Scopus
  36. J. C. Alexander, “Chemical and biological properties related to toxicity of heated fats,” Journal of Toxicology and Environmental Health, vol. 7, no. 1, pp. 125–138, 1981. View at Google Scholar · View at Scopus
  37. W. C. Byrdwell and W. E. Neff, “Autoxidation products of normal and genetically modified canola oil varieties determined using liquid chromatography with mass spectrometric detection,” Journal of Chromatography A, vol. 905, no. 1-2, pp. 85–102, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Wassmann, K. Wassmann, and G. Nickenig, “Modulation of oxidant and antioxidant enzyme expression and function in vascular cells,” Hypertension, vol. 44, no. 4, pp. 381–386, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. S. Wassmann, K. Wassmann, and G. Nickenig, “Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease,” Current Hypertension Reports, vol. 8, no. 1, pp. 69–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Parthasarathy, N. K. Merchant, M. Penumetcha, and N. Santanam, “Oxidation and cardiovascular disease—potential role of oxidants in inducing antioxidant defense enzymes,” Journal of Nuclear Cardiology, vol. 8, no. 3, pp. 379–389, 2001. View at Google Scholar
  41. J. Fruebis, S. Parthasarathy, and D. Steinberg, “Evidence for a concerted reaction between lipid hydroperoxides and polypeptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 22, pp. 10588–10592, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, p. E45, 2001. View at Google Scholar · View at Scopus
  43. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  44. K. Jaworski, F. Kinard, D. Goldstein et al., “S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells,” European Journal of Pharmacology, vol. 425, no. 1, pp. 11–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. J. S. Yuan, A. Reed, F. Chen, and C. N. Stewart, “Statistical analysis of real-time PCR data,” BMC Bioinformatics, vol. 7, article no. 85, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. M. H. Hsu, U. Savas, K. J. Griffin, and E. F. Johnson, “Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in HepG2 cells,” Journal of Biological Chemistry, vol. 276, no. 30, pp. 27950–27958, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. Heinaniemi, J. O. Uski, T. Degenhardt, and C. Carlberg, “Meta-analysis of primary target genes of peroxisome proliferator-activated receptors,” Genome Biology, vol. 8, no. 7, article R147, 2007. View at Publisher · View at Google Scholar · View at PubMed
  48. Y. I. Miller, S. H. Choi, L. Fang, and S. Tsimikas, “Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis,” Sub-Cellular Biochemistry, vol. 51, pp. 229–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Furnkranz, A. Schober, V. N. Bochkov et al., “Oxidized phospholipids trigger atherogenic inflammation in murine arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 3, pp. 633–638, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. Barlic, Y. Zhang, and P. M. Murphy, “Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFα-NFκB-dependent manner,” Journal of Biological Chemistry, vol. 282, no. 26, pp. 19167–19176, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. K. G. Birukov, “Oxidized lipids: the two faces of vascular inflammation,” Current Atherosclerosis Reports, vol. 8, no. 3, pp. 223–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac, “Invited review: potential role of oxidized lipids and lipoproteins in antioxidant defense,” Free Radical Research, vol. 33, no. 3, pp. 197–215, 2000. View at Google Scholar · View at Scopus
  53. E. Niki, “Lipid peroxidation: physiological levels and dual biological effects,” Free Radical Biology and Medicine, vol. 47, no. 5, pp. 469–484, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. C. Doran, N. Meller, and C. A. McNamara, “Role of smooth muscle cells in the initiation and early progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812–819, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. M. E. Rosenfeld, “Inflammation, lipids, and free radicals: lessons learned from the atherogenic process,” Seminars in Reproductive Endocrinology, vol. 16, no. 4, pp. 249–261, 1998. View at Google Scholar · View at Scopus
  56. B. Friedrichs, M. Toborek, B. Hennig, L. Heinevetter, C. Müller, and R. Brigelius-Flohé, “13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently,” BioFactors, vol. 9, no. 1, pp. 61–72, 1999. View at Google Scholar · View at Scopus
  57. S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac, “Potential role of oxidized lipids and lipoproteins in antioxidant defense,” Free Radical Research, vol. 33, no. 3, pp. 197–215, 2000. View at Google Scholar · View at Scopus
  58. O. Meilhac, M. Zhou, N. Santanara, and S. Parthasarathy, “Lipid peroxides induce expression of catalase in cultured vascular cells,” Journal of Lipid Research, vol. 41, no. 8, pp. 1205–1213, 2000. View at Google Scholar · View at Scopus
  59. C. Marantos, V. Mukaro, J. Ferrante, C. Hii, and A. Ferrante, “Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids,” American Journal of Pathology, vol. 173, no. 4, pp. 1057–1066, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. A. Huang, C. Li, R. L. Kao, and W. L. Stone, “Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages,” Free Radical Biology and Medicine, vol. 26, no. 5-6, pp. 526–537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. J. D. Kakisis, C. D. Liapis, and B. E. Sumpio, “Effects of cyclic strain on vascular cells,” Endothelium: Journal of Endothelial Cell Research, vol. 11, no. 1, pp. 17–28, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. T. A. McCaffrey, C. Fu, B. Du et al., “High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis,” Journal of Clinical Investigation, vol. 105, no. 5, pp. 653–662, 2000. View at Google Scholar · View at Scopus
  63. R. N. Hasan and A. I. Schafer, “Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-κB,” Circulation Research, vol. 102, no. 1, pp. 42–50, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. C. C. L. Wang, G. Sharma, and B. Draznin, “Early growth response gene-1 expression in vascular smooth muscle cells: effects of insulin and oxidant stress,” American Journal of Hypertension, vol. 19, no. 4, pp. 366–372, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. E. Harja, L. G. Bucciarelli, Y. Lu et al., “Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation,” Circulation Research, vol. 94, no. 3, pp. 333–339, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. N. Hamada, M. Miyata, H. Eto et al., “Loss of clusterin limits atherosclerosis in apolipoprotein E-deficient mice via reduced expression of Egr-1 and TNF-α,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 3, pp. 209–216, 2010. View at Google Scholar
  67. L. M. Khachigian, V. Lindner, A. J. Williams, and T. Collins, “Egr-1-induced endothelial gene expression: a common theme in vascular injury,” Science, vol. 271, no. 5254, pp. 1427–1431, 1996. View at Google Scholar · View at Scopus
  68. E. S. Silverman, L. M. Khachigian, V. Lindner, A. J. Williams, and T. Collins, “Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3,” American Journal of Physiology, vol. 273, no. 3, pp. H1415–H1426, 1997. View at Google Scholar · View at Scopus
  69. E. Biesiada, M. Razandi, and E. R. Levin, “Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation,” Journal of Biological Chemistry, vol. 271, no. 31, pp. 18576–18581, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ling, A. Dai, Y. H. Ma, K. Chatterjee, H. E. Ives, and K. Sudhir, “Matrix-dependent gene expression of Egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells,” Hypertension, vol. 34, no. 5, pp. 1141–1146, 1999. View at Google Scholar · View at Scopus
  71. N. Jin, N. D. Hatton, M. A. Harrington, X. Xia, S. H. Larsen, and R. A. Rhoades, “H(2)O(2)-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells,” Free Radical Biology and Medicine, vol. 29, no. 8, pp. 736–746, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Auge, N. Santanam, N. Mori, C. Keshava, and S. Parthasarathy, “Uptake of 13-hydroperoxylinoleic acid by cultured cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 925–931, 1999. View at Google Scholar · View at Scopus
  73. E. Blessing, M. Preusch, R. Kranzhofer et al., “Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice,” Atherosclerosis, vol. 199, no. 2, pp. 295–303, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. R. S. Chapkin, M. Young Hong, Y. Y. Fan et al., “Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function,” Lipids, vol. 37, no. 2, pp. 193–199, 2002. View at Google Scholar · View at Scopus
  75. S. S. Dadras, S. S. Thorgeirsson, M. S. Rao, and J. K. Reddy, “Implication of hydrogen peroxide generation and apoptosis in the neoplastic transformation of mouse fibroblasts overexpressing peroxisomal fatty acyl-CoA oxidase,” International Journal of Oncology, vol. 12, no. 1, pp. 37–44, 1998. View at Google Scholar · View at Scopus
  76. V. N. Bochkov, D. Mechtcheriakova, M. Lucerna et al., “Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT,” Blood, vol. 99, no. 1, pp. 199–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. J. J. Chiu, B. S. Wung, H. J. Hsieh, L. W. Lo, and D. L. Wang, “Nitric oxide regulates shear stress-induced early growth response-1: expression via the extracellular signal-regulated kinase pathway in endothelial cells,” Circulation Research, vol. 85, no. 3, pp. 238–246, 1999. View at Google Scholar · View at Scopus
  78. V. A. Folcik, R. A. Nivar-Aristy, L. P. Krajewski, and M. K. Cathcart, “Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 504–510, 1995. View at Google Scholar · View at Scopus
  79. K. Uchida, “Lipid peroxidation and redox-sensitive signaling pathways,” Current Atherosclerosis Reports, vol. 9, no. 3, pp. 216–221, 2007. View at Publisher · View at Google Scholar · View at Scopus